Terconazole and Otitis - a phase IV clinical study of FDA data

Summary:

Otitis is reported as a side effect among people who take Terconazole (terconazole), especially for people who are female, 40-49 old, also take Zyrtec, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Otitis when taking Terconazole. It is created by eHealthMe based on reports of 987 people who have side effects when taking Terconazole from the FDA, and is updated regularly.

What is Terconazole?

Terconazole has active ingredients of terconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 1,004 Terconazole users. Check the latest studies of Terconazole.

What is Otitis?

Otitis (ear infection) is found to be associated with 1,406 drugs and 1,842 conditions by eHealthMe. Check the latest studies of Otitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

987 people reported to have side effects when taking Terconazole.
Among them, 11 people (1.11%) have Otitis.

Among these 11 people:

What is the gender of people who have Otitis when taking Terconazole? *

female: 100 %
male: 0.0 %

What is the age of people who have Otitis when taking Terconazole? *

What are other drugs people take besides Terconazole? *

What are other side effects people have besides Otitis? *

Urinary Tract Infection: 8 people, 72.73%
Sinusitis (inflammation of sinus): 8 people, 72.73%
Infusion Related Reaction: 7 people, 63.64%
Stress And Anxiety: 7 people, 63.64%
Fatigue (feeling of tiredness): 7 people, 63.64%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 54.55%
Upper Respiratory Tract Infection: 6 people, 54.55%
Fall: 6 people, 54.55%
Rashes (redness): 6 people, 54.55%
Joint Pain: 5 people, 45.45%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 6 people, 54.55%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 45.45%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 4 people, 36.36%
Primary Immunodeficiency Syndrome: 3 people, 27.27%
Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 18.18%
High Blood Pressure: 2 people, 18.18%
Anaemia (lack of blood): 2 people, 18.18%
Calcium Deficiency (lack of calcium): 2 people, 18.18%
Gastric Ulcer (stomach ulcer): 2 people, 18.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Terconazole and have Otitis?

- Check whether Otitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Terconazole:

Terconazole (1,004 reports)

Otitis treatments and more:

Otitis (36,446 reports)

Browse all side effects of Terconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Otitis:

Otitis (1,406 drugs)

Browse all the conditions that are associated with Otitis:

Otitis (1,842 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on terconazole (the active ingredients of Terconazole) and Terconazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.